论文信息 - Risk and Severity of Cytokine Release Syndrome in Patients with Relapsed/Refractory (R/R) AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436 - 字舞流文

Risk and Severity of Cytokine Release Syndrome in Patients with Relapsed/Refractory (R/R) AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436

F. Uckun | C. Cogle | P. Patel | P. Shami | E. Cull | J. Watts | A. Mims | Cynthia Lee | T. Lin